Virios Therapeutics (VIRI) Tops Q3 EPS by 18c

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
• GE Vernova (GEV) PT Raised to $1,185 at Jefferies